Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2020-06-11 Capital/Financing Update
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
NAVAMEDIC ASA: PRELIMINARY RESULTS OF THE SUBSEQUENT OFFERING
Capital/Financing Update Classification · 98% confidence The document is titled "NAVAMEDIC ASA: PRELIMINARY RESULTS OF THE SUBSEQUENT OFFERING" and discusses the subscription period, preliminary counting of shares subscribed for (446,478 Offer Shares), expected final allocation dates, and payment due dates related to a share offering. This content directly relates to fundraising, capital structure changes, and the results of a securities offering. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital event.
2020-06-11 English
NAVAMEDIC ASA: LAST DAY OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING
Capital/Financing Update Classification · 98% confidence The document is a stock exchange announcement from Navamedic ASA regarding the 'LAST DAY OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING' of new shares. This announcement details the mechanics, deadlines, and legal restrictions related to a capital raising activity (offering of shares). This clearly falls under the category of updates on company fundraising or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). It is not a full report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it pertains specifically to a financing event.
2020-06-11 English
NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS
Share Issue/Capital Change Classification · 98% confidence The document explicitly states its purpose: 'RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS'. It details the issuance of new shares (46,875 new shares) to facilitate the exercise of vested share options. This action directly relates to changes in the company's capital structure through the issuance of new stock, which aligns precisely with the definition of 'Share Issue/Capital Change' (Code: SHA). It is not a general financing update (CAP), nor a transaction in own shares (POS), as it is specifically about issuing new shares due to option exercises, which is a capital change event.
2020-06-10 English
Navamedic ASA: Annual General Meeting held
AGM Information Classification · 100% confidence The document is explicitly titled "PROTOKOLL FRA ORDINÆR GENERALFORSAMLING" and "MINUTES OF ANNUAL GENERAL MEETING". It details the proceedings, resolutions passed (like election of officers, approval of annual accounts, determination of compensation), and voting results from a meeting held on June 3, 2020. This content perfectly matches the definition of an Annual General Meeting (AGM) record. Although it mentions the approval of the Annual Report (Årsrapport), the document itself is the record of the meeting where that approval took place, making AGM-R the most accurate classification.
2020-06-03 Norwegian
Navamedic ASA: Annual General Meeting held
AGM Information Classification · 98% confidence The document explicitly states that the 'Annual General Meeting' was held and that the 'minutes from the general meeting is attached hereto'. The document is very short (641 characters) and serves primarily to announce that the AGM occurred and the minutes are available, rather than being the full AGM presentation or the minutes themselves. This fits the description of a Report Publication Announcement (RPA) or a general regulatory announcement (RNS). Given the specific mention of the AGM and the attachment of minutes, AGM-R (AGM Information) is a strong candidate if the attachment *is* the AGM material, but the text structure strongly suggests an announcement *about* the meeting and the availability of the minutes. Since the text is an announcement regarding the holding of the AGM and the availability of its minutes, and it is very brief, it aligns best with either AGM-R (if interpreted as the primary output related to the AGM) or RPA (if interpreted as an announcement of published material). Since the core event is the AGM, AGM-R is the most specific fit for the subject matter, even if the format is an announcement.
2020-06-03 English
NAVAMEDIC ASA: APPROVED PROSPECTUS, LISTING OF PRIVATE PLACEMENT SHARES AND COMMENCEMENT OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING
Capital/Financing Update Classification · 98% confidence The document is a stock exchange announcement from NAVAMEDIC ASA regarding an 'APPROVED PROSPECTUS, LISTING OF PRIVATE PLACEMENT SHARES AND COMMENCEMENT OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING'. It details the approval of a prospectus for a subsequent offering and the listing of new shares resulting from a private placement. This activity directly relates to fundraising, capital structure changes, and the issuance of securities, which aligns with the definition of a Capital/Financing Update (CAP). Although it mentions a prospectus, the primary purpose of this specific announcement is to communicate the completion of financing steps and the commencement of the subscription period, rather than being the full prospectus itself or a general report announcement (RPA/RNS).
2020-05-27 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.